Loading stock…

Cardinal Health, Inc. (CAH) Stock Verdict & Ratings | Investment Bastion

Stock Verdict·Updated 1d ago

Cardinal Health, Inc.

CAHMarket cap $54BPrice $232.2

Country🇺🇸United States

SectorHealthcare

IndustryHealthcare Services

Distributes medical supplies, pharmaceuticals, and equipment to hospitals, pharmacies, and healthcare facilities across America. Touches nearly every prescription filled and medical procedure performed, making it the invisible backbone of US healthcare delivery.

In Bastion Portfolios?

52W Return+49%Global Market +16%?

01Key Ratings

How does this stock score across Bastion factors?

Growth

Historical Revenue

Rev CAGR (3y)+7%6

Revenue Forecast

Rev CAGR (1y)+4%4

Rev CAGR (3y)+5%4

Rev CAGR (5y)+4%4

Earnings Forecast

EPS Growth Y+1+74%10

EPS Growth Y+2+10%7

EPS Growth Y+3+8%6

Quality

Margins

EBIT Margin1%2

Net Income Margin1%2

Free Cash Flow Margin2%3

Debt

Net Debt/EBITDA1.16

Efficiency

ROEna–

ROA3%5

Earnings Stability88

GEAR+AVERAGE44

Overall rating across all five factors

Value

Price Multiples

P/E Ratio (Forward)184

P/E Ratio (Forward 3y)154

P/BVna–

EV Multiples

EV/EBITDA Fwd134

EV/EBIT Fwd156

Yield

Free Cash Flow Yield8.4%8

Dividend Yield0.9%3

Momentum

Short term

1 month return-3%6

3 month return-2%6

YTD return+14%7

Mid term

Price vs 52wHigh90%8

1 year return+49%9

Long term

3 year return+169%9

5 year return+428%10

Risk Shield

Price Risk

Beta0.39

Volatility29%7

Free Cash Flow

Free Cash Flow Margin2%3

Free Cash Flow Yield8.4%8

Quality

ROCE24%9

Earnings Stability88

Net Debt/EBITDA1.16

02Growth

Is it actually growing, and how fast?

CAHCardinal Health

Revenue FY26$254B

GROWTH RATING↗

AVERAGE41 / 100

REVENUE GROWTH▾SCORE

Revenue, last 3Y, CAGR+7%6

Revenue, next 1Y+4%4

Revenue, next 3Y, CAGR+5%4

Revenue, next 5Y, CAGR+4%4

EARNINGS FORECAST▾SCORE

EPS growth, FY27E+74%10

EPS growth, FY28E+10%7

EPS growth, FY29E+8%6

GROWTH ASSESSMENT

STRENGTHS

Earnings are set to grow in step with sales (EPS about 10%/yr vs revenue 5%/yr).

WATCH

A mid-pack grower, ahead of 41% of companies worldwide.

Revenue is set to grow 5%/yr over the next 3 years, a little behind the market.4/10

Revenue grew 7%/yr over the last 3 years and is set to keep growing around 5%/yr.

Over five years revenue is set to grow 4%/yr, behind 60% of companies worldwide.4/10

WEAKNESSES

None flagged.

BOTTOM LINE

Margin Expander

A middle-of-the-pack grower. The one thing to watch: forward revenue growth is only about average.

03Price Momentum

Is the market behind it right now?

MOMENTUM RATING↗

VERY STRONG86 / 100

SHORT-TERM RETURNS▾SCORE

1-month return-3%6

3-month return-2%6

YTD return+14%7

MID & LONG-TERM▾SCORE

% of 52-week high90%8

1-year return+49%9

3-year return+169%9

5-year return+428%10

MOMENTUM ASSESSMENT

STRENGTHS

Magnificent long-term results. Long-term holders have seen +169% over three years and +428% over five, ahead of 90% of the market.

It's up 49% over the past year, but 10% below its 52-week high. That is clearly ahead of the market.

Strong recent results. The stock is outperforming so far this year (+14%).

WATCH

Returns sit at the market level over the past month (-3%) and over three months (-2%).

WEAKNESSES

None flagged.

BOTTOM LINE

Steady Compounder

Dependable multi-year returns and the stock sits near its highs. A reliable trend, if not the single hottest name in the market.

04Value

Are you paying a fair price for it?

Stop guessing on Cardinal Health. Get the full investment case.

Premium

$20.75/month

Billed annually at $249/year $348

✓
Stock VerdictValuation and investment strategy for 4,000+ stocks. Days of hedge fund analyst research, done in 2 minutes.
✓
RadarFind your next investment idea: top-ranked stocks across all 9 Bastion strategies.
✓
Portfolio ManagerCheck if Bastion algorithms added the stock you care about to their portfolios.

Secure via Stripe

Trusted by 1,000+ investors in our community

Loading charts…

02Growth

Is it actually growing, and how fast?

CAHCardinal Health

Revenue FY26$254B

GROWTH RATING↗

AVERAGE41 / 100

REVENUE GROWTH▾SCORE

Revenue, last 3Y, CAGR+7%6

Revenue, next 1Y+4%4

Revenue, next 3Y, CAGR+5%4

Revenue, next 5Y, CAGR+4%4

EARNINGS FORECAST▾SCORE

EPS growth, FY27E+74%10

EPS growth, FY28E+10%7

EPS growth, FY29E+8%6

GROWTH ASSESSMENT

STRENGTHS

Earnings are set to grow in step with sales (EPS about 10%/yr vs revenue 5%/yr).

WATCH

A mid-pack grower, ahead of 41% of companies worldwide.

Revenue is set to grow 5%/yr over the next 3 years, a little behind the market.4/10

Revenue grew 7%/yr over the last 3 years and is set to keep growing around 5%/yr.

Over five years revenue is set to grow 4%/yr, behind 60% of companies worldwide.4/10

WEAKNESSES

None flagged.

BOTTOM LINE

Margin Expander

A middle-of-the-pack grower. The one thing to watch: forward revenue growth is only about average.

03Price Momentum

Is the market behind it right now?

MOMENTUM RATING↗

VERY STRONG86 / 100

SHORT-TERM RETURNS▾SCORE

1-month return-3%6

3-month return-2%6

YTD return+14%7

MID & LONG-TERM▾SCORE

% of 52-week high90%8

1-year return+49%9

3-year return+169%9

5-year return+428%10

MOMENTUM ASSESSMENT

STRENGTHS

Magnificent long-term results. Long-term holders have seen +169% over three years and +428% over five, ahead of 90% of the market.

It's up 49% over the past year, but 10% below its 52-week high. That is clearly ahead of the market.

Strong recent results. The stock is outperforming so far this year (+14%).

WATCH

Returns sit at the market level over the past month (-3%) and over three months (-2%).

WEAKNESSES

None flagged.

BOTTOM LINE

Steady Compounder

Dependable multi-year returns and the stock sits near its highs. A reliable trend, if not the single hottest name in the market.

04Value

Are you paying a fair price for it?

Stop guessing on Cardinal Health. Get the full investment case.

Premium

$20.75/month

Billed annually at $249/year $348

✓
Stock VerdictValuation and investment strategy for 4,000+ stocks. Days of hedge fund analyst research, done in 2 minutes.
✓
RadarFind your next investment idea: top-ranked stocks across all 9 Bastion strategies.
✓
Portfolio ManagerCheck if Bastion algorithms added the stock you care about to their portfolios.

Secure via Stripe

Trusted by 1,000+ investors in our community